NCT04997993 2025-06-25
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Icahn School of Medicine at Mount Sinai
Phase 1 Recruiting
Clinical Trials
1 trialsInterventional × PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer × 1 year × Clear all